Antiviral Medicine Produced by Valenta Led the Segment by the Results of Sales in January 2016

By the results of audit performed by DSM Group analytical agency, Valenta’s Ingavirin got the first place among antiviral medicines for flu in terms of sales value at Russian drugstores in January 2016. January sales of Ingavirin grew 3.3 times in comparison with the same period of 2015. The breakaway of the Company from its closest competitor by this parameter exceeded 20%.